Arca
Skip to content
Tools
Tools

The Livongo Health In Touch Blood Glucose Monitoring System (BGMS)

Recall Z-1587-2016, part of FDA recall event 73486. See Livongo Health's company page.

Livongo Health started this Class II device recall on Feb 18, 2016 (voluntary: firm initiated); FDA lists it as terminated, terminated Mar 6, 2018.

  • Classification: Class II
  • Started: Feb 18, 2016
  • Status: Terminated

Why It Was Recalled

Class II

The instructional insert for the In Touch Control Solution for use with the In Touch meter and In Touch strips as a quality control check did not contain the limitation of sensor accuracy: (1) with the use of acetaminophen (Tylenol) (2) with the use of Ascorbic Acid (vitamin C) supplementation (3) in the presence of uric acid

Record

Product
The Livongo Health In Touch Blood Glucose Monitoring System (BGMS), is an Over-The-Counter (OTC) system designed for the self- monitoring of blood glucose by persons with diabetes in home settings to aid in their diabetes management.
Quantity
63,000 units
Lots and codes
Model/Reorder Number 3614-001-001 with the following lot numbers 890071 890072, 890073, 890074, 890075, 890076, 890077, 890078 and 890079.
Distribution
US consignees: Arizona, California, Delaware, Florida, Georgia, Illinois, Kentucky, Maryland, Michigan, Minnesota, Mississippi, Missouri, Montana, New Jersey, New York, Ohio, Pennsylvania, South Carolina, Tennessee, Texas, Virginia and Washington.
Recalling firm
Livongo Health, Chicago, IL, United States
How the firm notified
Letter
FDA classified
Apr 29, 2016

FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA device enforcement reports

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.